Sign in

CIK 0001759138 · Non-accelerated filer<br>Smaller reporting company

Cabaletta Bio, Inc.

Sign in to watch
Ticker
CABA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(267) 759-3100
Business address
2929 ARCH STREET, SUITE 600, PHILADELPHIA, PA, 19104
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-01-21 Chang David J. Chief Medical Officer Purchase +8,800 $2.26 $20K 8,800
2026-01-21 Binder Gwendolyn President, Science & Tech. Purchase +11,312 $2.19 $25K 31,312
2026-01-21 Tomasello Shawn Director Purchase +22,725 $2.21 $50K 22,725
2026-01-21 Gavel Steve Chief Commercial Officer Purchase +22,170 $2.27 $50K 22,170
2026-01-21 Bollard Catherine Director Purchase +4,405 $2.27 $10K 5,405
2026-01-21 Nichtberger Steven President & CEO Purchase +45,000 $2.24 $101K 1,031,483
2026-01-21 Simon Mark Director Purchase +11,061 $2.28 $25K 147,205
2026-01-21 Gerard Michael General Counsel Purchase +6,600 $2.27 $15K 6,600
2022-10-19 Nichtberger Steven President & CEO Purchase +8,127 $1.25 $10K 986,483
2022-10-18 Bollard Catherine Director Purchase +1,000 $0.99 $994 1,000
2022-10-18 Marda Anup Chief Financial Officer Purchase +50,000 $0.99 $50K 50,000
2022-10-18 Simon Mark Director Purchase +118,000 $0.98 $115K 136,144
2022-10-18 Simon Mark Director Purchase +7,000 $0.98 $7K 7,000
2022-10-18 Binder Gwendolyn See Remarks Purchase +20,000 $0.99 $20K 20,000
2022-10-18 Nichtberger Steven President & CEO Purchase +141,873 $0.99 $141K 978,356
2019-10-29 5AM Ventures V, L.P. 10% owner Purchase +454,545 $11.00 $5.0M 454,545
2019-10-29 Flynn James E 10% owner Purchase +700,000 $11.00 $7.7M 700,000

Page 1 of 1 · 17 trades